文献速递病毒性肝炎

丙型肝炎血浆病毒第二相动力学直接反映肝内丙型肝炎病毒负荷的降低

Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus.
PubMed 文献 · J Infect Dis · 2023-01-01

该双盲随机对照试验采用单细胞方法,在10例慢性基因1a型HCV感染者中于直接抗病毒药物(DAA)治疗前及启动后7天内肝活检,定量HCV感染肝细胞。感染肝细胞中位比例从11.3%降至0.6%,血浆病毒血症与感染肝细胞数相关(r=0.77;P<.0001),第二相血浆动力学与感染肝细胞变化无显著差异(P=.16),证明第二相病毒动力学源于感染细胞减少。

要点

  • 感染肝细胞中位比例从11.3%(范围1.3%-59%)降至0.6%(范围<0.3%-5.8%),丢失75%-95%感染肝细胞。
  • 血浆病毒血症与HCV感染肝细胞数相关(r=0.77;P<.0001)。
  • 第二相血浆动力学与感染肝细胞变化无显著差异(P=.16),证明其源于感染细胞减少。

核心结论

  • 证明第二相病毒动力学反映肝内HCV负荷的衰减,部分由于肝细胞中HCV RNA的清除。

研究设计与样本

  • 双盲随机对照试验,比较2种(索磷布韦-维帕他韦)与3种(索磷布韦-维帕他韦-伏西拉韦)DAA方案。
  • 采用单细胞方法,在治疗前及启动DAA后7天内肝活检,定量HCV感染肝细胞。
  • 纳入10例慢性基因1a型HCV感染者,进行数千次肝内测量。

主要发现

  • 感染肝细胞中位比例从11.3%(范围1.3%-59%)降至0.6%(范围<0.3%-5.8%),丢失75%-95%感染肝细胞。
  • 血浆病毒血症与HCV感染肝细胞数相关(r=0.77;P<.0001)。
  • 第二相血浆动力学与感染肝细胞变化无显著差异(P=.16)。
  • DAA导致细胞内HCV RNA和干扰素刺激基因表达下降(两者P<.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mathematical models explain how antivirals control viral infections. Hepatitis C virus (HCV) treatment results in at least 2 phases of decline in viremia. The first phase reflects clearance of rapidly produced virions. The second phase is hypothesized to derive from loss of infected cells but has been challenging to prove. METHODS: Using single-cell methods, we quantified the number of hepatitis C virus (HCV)-infected hepatocytes in liver biopsies taken before and within 7 days of initiating direct-acting antivirals (DAAs) in a double-blinded randomized controlled trial testing 2 (sofosbuvir-velpatasvir) versus 3 (sofosbuvir-velpatasvir-voxilaprevir) DAAs. RESULTS: We employed thousands of intrahepatic measurements in 10 persons with chronic genotype 1a HCV infection: median proportion of infected hepatocytes declined from 11.3% (range, 1.3%-59%) to 0.6% (range, <0.3%-5.8%), a loss of 75%-95% infected hepatocytes. Plasma viremia correlated with numbers of HCV-infected hepatocytes (r = 0.77; P < .0001). Second-phase plasma dynamics and changes in infected hepatocytes were indistinct (P = .16), demonstrating that second-phase viral dynamics derive from loss of infected cells. DAAs led to a decline in intracellular HCV RNA and interferon-stimulated gene expression (P < .05 for both). CONCLUSIONS: We proved that second-phase viral dynamics reflect decay of intrahepatic burden of HCV, partly due to clearance of HCV RNA from hepatocytes. CLINICAL TRIALS REGISTRATION: NCT02938013.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sachithanandham J, Balagopal A, Leep-Lazar J, et al. Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus. J Infect Dis. 2023. PMID: 36722133. doi:10.1093/infdis/jiad025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。